Latest News about Pharma/Biotech
Recent news which mentions Pharma/Biotech
Week In Review: Adlai Nortye Stages $97.5 Million US IPO On Nasdaq
September 30, 2023
From TalkMarkets
Some Economics Of Pharmacy Benefit Managers
September 28, 2023
From TalkMarkets
Roivant Stock Price Outlook: Strong Pipeline Is A Catalyst
September 27, 2023
From TalkMarkets
Psychedelic Drug Stocks Dragged Down By 83% Collapse In SEEL Stock Price
September 24, 2023
From TalkMarkets
Week In Review: Everest Acquires Novel Autoimmune Therapy In $132 Million Agreement
September 23, 2023
From TalkMarkets
How The Same Treatments May Work For Multiple Neurodegenerative Diseases
September 21, 2023
From TalkMarkets
From TalkMarkets
4 Of The 6 Largest Psychedelic Compound-Based R & D Stocks Had A Good Week
September 17, 2023
From TalkMarkets
Week In Review: Hasten Signs $325 Million Deal For China Rights To PCSK9 Cholesterol Therapy
September 16, 2023
From TalkMarkets
Healthcare Playbook Revisited - Growth Plus Value
September 13, 2023
From TalkMarkets
CVS And Cigna Charge $6,000 For $55 Generics, How Do We Fix This?
September 12, 2023
From TalkMarkets
Roivant Sciences: Is Vivek Ramaswamy’s Biotech Stock A Buy?
September 10, 2023
Tickers
ROIV
From TalkMarkets
6 Largest Psychedelic Compound-Based R & D Stocks In Decline
September 10, 2023
From TalkMarkets
Healthcare Portfolio: A Mixed Market Looking for Value
September 05, 2023
From TalkMarkets
From TalkMarkets
Week In Review: GenFleet Out-Licenses Three Candidates To Verastem In $625 Million Deal
September 02, 2023
From TalkMarkets
The Truth About IPO Investing
September 02, 2023
From TalkMarkets
August Recap: Largest Psychedelic Compound-Based R & D Stocks Down 15%
September 02, 2023
From TalkMarkets
From TalkMarkets
From TalkMarkets
Week In Review: A Consortium Of China Drug Distributors Want To Acquire Poland's Neuca
August 26, 2023
From TalkMarkets
6 Largest Psychedelic Compound-Based R&D Stocks Continued Downwards, On Average, This Week
August 25, 2023
From TalkMarkets
Tuesday Talk: Monday Rebound
August 22, 2023
From TalkMarkets
Gene Therapy Breakthroughs On The Horizon
August 21, 2023
From TalkMarkets
Large Cap Biopharmaceuticals Performance 2023 YTD: Mixed Results But Lilly Is A Big Winner
August 21, 2023
From TalkMarkets
From TalkMarkets
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.